These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19571208)

  • 1. Neuropeptide Y and neurovascular control in skeletal muscle and skin.
    Hodges GJ; Jackson DN; Mattar L; Johnson JM; Shoemaker JK
    Am J Physiol Regul Integr Comp Physiol; 2009 Sep; 297(3):R546-55. PubMed ID: 19571208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y antagonism reduces reflex cutaneous vasoconstriction in humans.
    Stephens DP; Saad AR; Bennett LA; Kosiba WA; Johnson JM
    Am J Physiol Heart Circ Physiol; 2004 Sep; 287(3):H1404-9. PubMed ID: 15165988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen modulates the contribution of neuropeptide Y to baseline hindlimb blood flow control in female Sprague-Dawley rats.
    Jackson DN; Ellis CG; Shoemaker JK
    Am J Physiol Regul Integr Comp Physiol; 2010 May; 298(5):R1351-7. PubMed ID: 20219870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-diabetes augments neuropeptide Y1- and α1-receptor control of basal hindlimb vascular tone in young ZDF rats.
    Novielli NM; Al-Khazraji BK; Medeiros PJ; Goldman D; Jackson DN
    PLoS One; 2012; 7(10):e46659. PubMed ID: 23071607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y not involved in cutaneous vascular control in young human females taking oral contraceptive hormones.
    Hodges GJ; Martin ZT; Del Pozzi AT
    Microvasc Res; 2017 Sep; 113():9-15. PubMed ID: 28427990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoconstriction in exercising skeletal muscles: a potential role for neuropeptide Y?
    Buckwalter JB; Hamann JJ; Kluess HA; Clifford PS
    Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H144-9. PubMed ID: 15210450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of endothelial nitric oxide synthase, noradrenaline, and neuropeptide Y to local warming-induced cutaneous vasodilatation in men.
    Hodges GJ; Sparks PA
    Microvasc Res; 2013 Nov; 90():128-34. PubMed ID: 24012636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is tonic sympathetic vasoconstriction increased in the skeletal muscle vasculature of aged canines?
    DeLorey DS; Buckwalter JB; Mittelstadt SW; Anton MM; Kluess HA; Clifford PS
    Am J Physiol Regul Integr Comp Physiol; 2010 Nov; 299(5):R1342-9. PubMed ID: 20702803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y1 receptor vasoconstriction in exercising canine skeletal muscles.
    Buckwalter JB; Hamann JJ; Clifford PS
    J Appl Physiol (1985); 2005 Dec; 99(6):2115-20. PubMed ID: 16099895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo mechanisms of cutaneous vasodilation and vasoconstriction in humans during thermoregulatory challenges.
    Kellogg DL
    J Appl Physiol (1985); 2006 May; 100(5):1709-18. PubMed ID: 16614368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms and modifiers of reflex induced cutaneous vasodilation and vasoconstriction in humans.
    Charkoudian N
    J Appl Physiol (1985); 2010 Oct; 109(4):1221-8. PubMed ID: 20448028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension.
    Hartl J; Dietrich P; Moleda L; Müller-Schilling M; Wiest R
    Liver Int; 2015 Dec; 35(12):2556-63. PubMed ID: 26010514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo receptor characterization of neuropeptide Y-induced effects in consecutive vascular sections of cat skeletal muscle.
    Ekelund U; Erlinge D
    Br J Pharmacol; 1997 Feb; 120(3):387-92. PubMed ID: 9031740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
    Modin A
    Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
    Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reflex vasoconstriction in aged human skin increasingly relies on Rho kinase-dependent mechanisms during whole body cooling.
    Lang JA; Jennings JD; Holowatz LA; Kenney WL
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1792-7. PubMed ID: 19717729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM; Modin A
    Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic regulation of skeletal muscle blood flow in the pig: a non-adrenergic component likely to be mediated by neuropeptide Y.
    Modin A; Pernow J; Lundberg JM
    Acta Physiol Scand; 1993 May; 148(1):1-11. PubMed ID: 8333291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous vasomotor effects of neuropeptide Y.
    Hashim MA; Tadepalli AS
    Neuropeptides; 1995 Nov; 29(5):263-71. PubMed ID: 8587662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.
    Wiest R; Jurzik L; Moleda L; Froh M; Schnabl B; von Hörsten S; Schölmerich J; Straub RH
    J Hepatol; 2006 Mar; 44(3):512-9. PubMed ID: 16324766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.